Pure Global

Cardiac Rehabilitation Program in Patients With Cardiovascular Disease - Trial NCT06211361

Access comprehensive clinical trial information for NCT06211361 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Castilla-La Mancha and is currently Not yet recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06211361
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06211361
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
Impact of a Cardiac Rehabilitation Program in Patients With Cardiovascular Disease

Study Focus

Cardiovascular Diseases

Cardiac rehabilitation

Interventional

other

Sponsor & Location

University of Castilla-La Mancha

Cuenca, Spain

Timeline & Enrollment

N/A

Jan 08, 2024

Mar 30, 2024

80 participants

Primary Outcome

Change in peak oxygen uptake,Change in cardiorespiratory fitness

Summary

This protocol study aims to evaluate the effectiveness of a cardiac rehabilitation
 intervention program in patients with cardiovascular diseases to improve both anthropometric
 and biochemical data, as well as other variables related to cardiovascular disorders
 (cardiorespiratory fitness, muscle strength, โ€ฆ), and emotional aspects (anxiety, depression).
 
 Additionally, this study aims to evaluate the effectiveness of the cardiac rehabilitation
 program in improving body composition (waist circumference and body fat percentage), blood
 pressure and health-related quality of life.
 
 Objectives: i) To assess the functional capacity of patients with a recent cardiovascular
 event (acute coronary syndrome, onset heart failure, valve or bypass surgery) or with chronic
 decompensated cardiovascular disease (valvulopathy, pulmonary hypertension, congenital heart
 disease, heart failure) chronic), ii) to determine the different cardiorespiratory parameters
 obtained from cardiopulmonary exercise testing (CPET), iii) to determine the lifestyle habits
 and cardiovascular risk factors, iv) to develop a cardiac rehabilitation program according to
 and adapted to the need of each of these patients, v) to estimate the effect of the
 intervention, both in the muscle strength and in post-intervention CPET, biochemical and
 anthropometric parameters, v) to estimate the effect of the intervention in the quality of
 life, anxiety, depression, and adherence to the Mediterranean diet.

ICD-10 Classifications

Cardiovascular disease, unspecified
Hypertensive heart disease
Other ill-defined heart diseases
Heart disease, unspecified
Observation for other suspected cardiovascular diseases

Data Source

ClinicalTrials.gov

NCT06211361

Non-Device Trial